Loading
EI
Endocyte Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 20 Jan 2016.
Endocyte Inc: what insiders have been doing
This page follows insider dealings at Endocyte Inc as filed with SEC (Form 4). Endocyte Inc has had no insider filing for more than a year; the last one goes back to 8 February 2016.
In the same market, recent insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
24
Thresholds
n/a
Buy Volume
n/a
2 ops. · all time
Sell Volume
n/a
n/a
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Net income-US$47.7M
Last declaration on 8 February 2016
Declarations24 total
10,000 sharesCommon StockSEC:0001144204-16-079686:0
5,000 sharesCommon StockSEC:0001144204-16-079687:0
618 sharesCommon StockSEC:0001144204-16-079687:1
580 sharesCommon StockSEC:0001144204-16-079687:2
8,750 sharesCommon StockSEC:0001144204-16-079689:0
1,078 sharesCommon StockSEC:0001144204-16-079689:1
694 sharesCommon StockSEC:0001144204-16-079689:2
8,750 sharesCommon StockSEC:0001144204-16-079690:0
1,081 sharesCommon StockSEC:0001144204-16-079690:1
695 sharesCommon StockSEC:0001144204-16-079690:2
8,750 sharesCommon StockSEC:0001144204-16-079691:0
1,081 sharesCommon StockSEC:0001144204-16-079691:1
695 sharesCommon StockSEC:0001144204-16-079691:2
14,375 sharesCommon StockSEC:0001144204-16-079692:0
1,771 sharesCommon StockSEC:0001144204-16-079692:1
694 sharesCommon StockSEC:0001144204-16-079692:2
525 sharesCommon StockSEC:0001144204-16-079693:1
6,250 sharesCommon StockSEC:0001144204-16-079694:0
26,875 sharesCommon StockSEC:0001144204-16-079688:0
3,320 sharesCommon StockSEC:0001144204-16-079688:1
2,085 sharesCommon StockSEC:0001144204-16-079688:2
3,750 sharesCommon StockSEC:0001144204-16-079693:0
20,000 sharesCommon StockSEC:0001144204-16-076291:0
Canonical exit: 14 Apr 2016 (T+90)
10,000 sharesCommon StockSEC:0001144204-16-076291:1
Canonical exit: 18 Apr 2016 (T+90)
24 of 24 declarations
About Endocyte Inc
Endocyte Inc is a company focused on developing targeted therapies for cancer treatment. It is listed on the XNAS market.
